The alpha-hemolysin structural gene, hly+, previously cloned, insertionally inactivated, and introduced into the chromosome by allele replacement (M. 0. O'Reilly, J. C. S. De Azavedo, S. Kennedy, and T. J. Foster, Microb. Pathog. 1:125-138, 1986), was shown by protoplast fusion and transformation to be in the gene order purC-hly-uraB-fl[chr::Tn916]1101-thrB on the chromosome of Staphylococcus aureus NCTC 8325. This location is clearly distinct from that of the agr determinant, a regulatory gene affecting several extracellular proteins, including alpha-hemolysin, located between tmn and ilv.
purC-hly-uraB-fl[chr::Tn916]1101-thrB on the chromosome of Staphylococcus aureus NCTC 8325. This location is clearly distinct from that of the agr determinant, a regulatory gene affecting several extracellular proteins, including alpha-hemolysin, located between tmn and ilv.
Alpha-hemolysin is among the most important of the extracellular toxins produced by virulent strains of Staphylococcus aureus. The genetic control over alpha-hemolysin production in S. aureus has been the subject of several studies, among the first of which were the reports by McClatchy and Rosenblum (9, 10) , who isolated several alpha-hemolysin-deficient mutants of strain 233. Brown and Pattee (2) used transformation to analyze several spontaneous and induced alpha-hemolysin-deficient mutants, including representatives from those studied by McClatchy and Rosenblum. These mutations, then designated hla, were all shown to occupy the same chromosomal region between purB and ilv on the S. aureus NCTC 8325 chromosome. Because hla mutations also resulted in a deficiency in fibrinolysin production, it was unclear whether hla was in the structural gene for the alpha-hemolysin (2). Mallonee et al. (8) subsequently identified a TnSSJ-induced hla mutation that shared this region of the chromosome. The erythromycin resistance (Em') phenotype of this mutation made it readily portable. Consequently, to satisfy biohazard containment requirements, it has been introduced into strains used in in vitro recombinant DNA analyses of several toxins (1, 5). Recsei et al. (16) now have shown that hla, rather than being a mutation in the structural gene for alpha-hemolysin, is in a regulatory element that they have redesignated agr (for accessory gene regulator) whose insertional inactivation by TnS51 results in about a 50-fold reduction in the production of the alpha-, beta-, and delta-hemolysins, the toxic shock syndrome toxin, and staphylokinase and in a 20-fold increase in the secretion of protein A. Many of these conclusions about agr have been confirmed (12) .
The structural gene for alpha-hemolysin (the hly+ gene) has been cloned from the Wood 46 strain of S. aureus and introduced into Escherichia coli, Bacillus subtilis, and S. aureus, where it is expressed (3, 4) . The cloned gene, which is homologous with the hly+ gene of S. aureus NCTC 8325 (12) , has been insertionally inactivated by site-directed mutagenesis in vitro by insertion of a 1.4-kilobase TaqI fragment of pE194 that encodes Emr (12) . The resulting inactive hly gene was used to replace the wild-type structural gene by allele replacement in strain NCTC 8325 (12) . These strain and gene manipulations provided the opportunity to unambiguously identify the chromosomal location of the alphatoxin structural gene, which is the subject of this report.
The strains of S. aureus used in this study, summarized in Table 1 , were maintained as described previously (17) . The markers used in the genetic analyses and their chromosomal loci are summarized in Fig. 1 . Protoplast fusions were performed as described previously (17) . Transformations were performed as described previously (15) , except that cells were grown to competence in tryptone soya broth pur-14 13 showing the location of the markers used for mapping and other markers relevant to the present study. Markers: thy, thymine requirement; tyrB, tyrosine requirement; Q134 and fQ40, chromosomal insertion sites of TnSSI; rib, riboflavin requirement; tmn, constitutive tetracycline-minocycline resistance; f1109, chromosomal insertion of Tn4001; purB, adenine + guanine requirement; agr, accessory gene regulator; ilv, isoleucine-valine requirement; pig, absence of golden-yellow pigment; uraA and uraB, uracil requirement; his, histidine requirement; nov, novobiocin resistance; mec, methicillin resistance; tet, inducible tetracycline resistance; fus, fusidic acid resistance; pur-140 and purC, purine requirement; f1101, chromosomal insertion of Tn9O6; thrB, threonine requirement; trp, tryptophan requirement. The map is divided into segments 1 through 18, the ends of each of which are defined by a pair of cotransformable markers except where the circle is dashed; the dashed segments reflect gaps which exceed the capacity of currently available transforming DNA. (The figure is derived from a map shown in reference 6.) Fig. 1 ). Although the nov-thrB region is a significant portion of the known chromosome and includes three gaps of unknown size, these results simplified the task of identifying the specific location of hly by transformation.
Previously identified selectable markers known to be immediately counterclockwise from thrB are all TnS51 insertions (fQ40, uraB, and purC; segments 14 through 16, Fig. 1 (18) indicate that hly is between uraB and purC (segment 14, Fig. 1 Identification of the chromosomal locus of the hly+ structural gene confirms the earlier observation (2, 16) that the agr gene (segment 6, Fig. 1) is not the alpha-hemolysin structural gene. agr and hly occupy distinctly different chromosomal loci, and the identity of hly+ as the alphahemolysin structural gene is unambiguous.
Cloning of extracellular toxins of S. aureus often must be done by using strains that are unable to produce alphahemolysin to satisfy biohazard containment requirements (1, 5) . In the past, this requirement was met by using strains that carried the agr mutation, whose portability into various genetic backgrounds was facilitated by the Emr phenotype of Tn551 inserted into this gene (8) . Such strains, however, can still possess an intact structural gene for alpha-hemolysin.
The availability of the hly mutations and a knowledge of their chromosomal location should facilitate strain constructions that more directly satisfy the requirement that such strains be unable to produce alpha-hemolysin and be incapable of serving as an inadvertant source of the alpha-hemolysin structural gene during cloning experiments.
